Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK PHARMA vs INDOCO REMEDIES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GSK PHARMA INDOCO REMEDIES GSK PHARMA/
INDOCO REMEDIES
 
P/E (TTM) x 62.2 30.0 207.2% View Chart
P/BV x 18.9 2.9 641.1% View Chart
Dividend Yield % 1.6 0.7 240.4%  

Financials

 GSK PHARMA   INDOCO REMEDIES
EQUITY SHARE DATA
    GSK PHARMA
Mar-23
INDOCO REMEDIES
Mar-23
GSK PHARMA/
INDOCO REMEDIES
5-Yr Chart
Click to enlarge
High Rs1,684423 397.9%   
Low Rs1,231308 399.6%   
Sales per share (Unadj.) Rs191.9181.1 106.0%  
Earnings per share (Unadj.) Rs35.915.4 232.4%  
Cash flow per share (Unadj.) Rs39.823.1 172.1%  
Dividends per share (Unadj.) Rs32.002.25 1,422.2%  
Avg Dividend yield %2.20.6 356.8%  
Book value per share (Unadj.) Rs102.9111.5 92.3%  
Shares outstanding (eoy) m169.4192.15 183.8%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x7.62.0 376.1%   
Avg P/E ratio x40.623.7 171.6%  
P/CF ratio (eoy) x36.715.8 231.7%  
Price / Book Value ratio x14.23.3 432.1%  
Dividend payout %89.214.6 612.1%   
Avg Mkt Cap Rs m246,85833,683 732.9%   
No. of employees `000NANA-   
Total wages/salary Rs m5,9503,226 184.4%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m32,51716,686 194.9%  
Other income Rs m1,00724 4,222.4%   
Total revenues Rs m33,52416,710 200.6%   
Gross profit Rs m8,0332,860 280.8%  
Depreciation Rs m658706 93.1%   
Interest Rs m18250 7.2%   
Profit before tax Rs m8,3641,928 433.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,288505 452.6%   
Profit after tax Rs m6,0761,423 427.2%  
Gross profit margin %24.717.1 144.1%  
Effective tax rate %27.426.2 104.3%   
Net profit margin %18.78.5 219.2%  
BALANCE SHEET DATA
Current assets Rs m24,9438,082 308.6%   
Current liabilities Rs m13,2644,245 312.4%   
Net working cap to sales %35.923.0 156.2%  
Current ratio x1.91.9 98.8%  
Inventory Days Days9725 387.9%  
Debtors Days Days216768 28.1%  
Net fixed assets Rs m6,9889,055 77.2%   
Share capital Rs m1,694184 919.2%   
"Free" reserves Rs m15,73510,092 155.9%   
Net worth Rs m17,43010,276 169.6%   
Long term debt Rs m01,435 0.0%   
Total assets Rs m31,93017,137 186.3%  
Interest coverage x462.68.7 5,315.4%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x1.01.0 104.6%   
Return on assets %19.19.8 195.5%  
Return on equity %34.913.8 251.8%  
Return on capital %48.118.6 258.6%  
Exports to sales %047.5 0.0%   
Imports to sales %48.111.5 418.3%   
Exports (fob) Rs mNA7,919 0.0%   
Imports (cif) Rs m15,6301,917 815.2%   
Fx inflow Rs m1,6227,919 20.5%   
Fx outflow Rs m15,6301,917 815.2%   
Net fx Rs m-14,0086,002 -233.4%   
CASH FLOW
From Operations Rs m4,8421,788 270.8%  
From Investments Rs m8,079-2,082 -388.1%  
From Financial Activity Rs m-15,433228 -6,767.8%  
Net Cashflow Rs m-2,512-65 3,847.0%  

Share Holding

Indian Promoters % 0.0 58.7 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 11.6 21.3 54.5%  
FIIs % 2.9 1.7 173.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 41.3 60.6%  
Shareholders   114,663 32,600 351.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GSK PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on GSK Pharma vs Indoco Remedies

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

GSK Pharma vs Indoco Remedies Share Price Performance

Period GSK Pharma Indoco Remedies S&P BSE HEALTHCARE
1-Day 3.26% -1.81% 1.18%
1-Month -9.77% -6.44% -0.75%
1-Year 52.63% 1.11% 61.82%
3-Year CAGR 10.89% 4.71% 18.16%
5-Year CAGR 8.44% 11.97% 19.79%

* Compound Annual Growth Rate

Here are more details on the GSK Pharma share price and the Indoco Remedies share price.

Moving on to shareholding structures...

The promoters of GSK Pharma hold a 75.0% stake in the company. In case of Indoco Remedies the stake stands at 58.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of GSK Pharma and the shareholding pattern of Indoco Remedies.

Finally, a word on dividends...

In the most recent financial year, GSK Pharma paid a dividend of Rs 32.0 per share. This amounted to a Dividend Payout ratio of 89.2%.

Indoco Remedies paid Rs 2.3, and its dividend payout ratio stood at 14.6%.

You may visit here to review the dividend history of GSK Pharma, and the dividend history of Indoco Remedies.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.